PT-141
Bremelanotide (Melanocortin Receptor Agonist)
7 Amino Acids · MW: 1,025.2 Da
Amino Acids
7
Molecular Weight
1,025.2 Da
Half-life
~2.7 hours
Research Score
4.6
Studies
178
Storage
N/A
What is PT-141?
PT-141 (Bremelanotide) is a melanocortin receptor agonist FDA-approved as Vyleesi for hypoactive sexual desire disorder in premenopausal women. Unlike PDE5 inhibitors, it works through the central nervous system to enhance sexual arousal and desire. Derived from Melanotan II research.
Key Benefits & Mechanisms
Enhances sexual desire and arousal
Works through CNS (not vascular)
FDA-approved for HSDD
Effective for both men and women
Does not require sexual stimulation to work
Alternative to PDE5 inhibitors
Rapid onset of action
Research Summary
PT-141 has robust clinical evidence including multiple Phase III trials. FDA-approved in 2019. Unique mechanism of action through melanocortin-4 receptors in the brain. Well-characterized safety and efficacy profile.
Related Peptides
Ipamorelin
Growth Hormone Secretagogue
Ipamorelin is a selective growth hormone secretagogue that stimulates natural GH release without significantly affecting cortisol or prolactin levels. It is considered one of the safest and most selective GHRPs available.
PerformanceCJC-1295
Growth Hormone Releasing Hormone Analog
CJC-1295 is a modified GHRH analog with an extended half-life due to Drug Affinity Complex (DAC) technology. It promotes sustained, pulsatile GH release, improving body composition, recovery, and sleep quality.
PerformanceGHRP-6
Growth Hormone Releasing Peptide-6
GHRP-6 is a hexapeptide that stimulates the ghrelin receptor to promote growth hormone release. It is one of the earliest and most studied GH secretagogues, known for significant GH pulse induction and appetite stimulation.
PerformanceIGF-1 LR3
Insulin-like Growth Factor-1 Long R3
IGF-1 LR3 is a modified version of IGF-1 with 13 times the half-life of native IGF-1. It promotes anabolic signaling, muscle hyperplasia, and cellular repair with extended bioavailability.
Performance